Mirae Asset Global Investments’s Enanta Pharmaceuticals ENTA Stock Holding History

Mirae Asset Global Investments’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19K	Sell	1,300 -214	-14%	-$2.88K	﹤0.01%	1495
2026 Q1	$19.1K	Sell	1,514 -2,070	-58%	-$27.7K	﹤0.01%	1436
2025 Q4	$56.5K	Buy	3,584 +2,758	+334%	+$35K	﹤0.01%	1368
2025 Q3	$9.89K	Hold	826	–	–	﹤0.01%	1577
2025 Q2	$6.25K	Buy	826 +112	+16%	+$674	﹤0.01%	1531
2025 Q1	$4.08K	Buy	714 +8	+1%	+$49	﹤0.01%	1521
2024 Q4	$4.24K	Buy	+706	New	+$6.77K	﹤0.01%	1566
2023 Q3	–	Sell	-12,851	Closed	-$273K	–	2593
2023 Q2	$273K	Buy	12,851 +1,908	+17%	+$56.3K	﹤0.01%	2220
2023 Q1	$443K	Buy	+10,943	New	+$523K	﹤0.01%	1988

Other funds holding ENTA

CCIA

Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Mirae Asset Global Investments's ENTA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Enanta Pharmaceuticals (ENTA) stake by 14% in Q2 2026, selling an estimated $2.88K and leaving 1,300 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1495.

Mirae Asset Global Investments first reported a position in ENTA in Q1 2023 and has held it in 9 quarters since. The position peaked at $443K in Q1 2023. 22 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

Mirae Asset Global Investments held 1,300 shares of Enanta Pharmaceuticals worth $19K as of Q2 2026.
Mirae Asset Global Investments sold 214 Enanta Pharmaceuticals shares in Q2 2026, an estimated $2.88K.
Enanta Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1495 holding.
Mirae Asset Global Investments first reported a position in Enanta Pharmaceuticals in Q1 2023 and has held it in 9 quarters since.
Mirae Asset Global Investments's Enanta Pharmaceuticals position peaked at $443K in Q1 2023.
22 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.